IL150525A0 - 2-carboxamide-benzimidazoles useful in the treatment and prevention of isochemic reperfusion injury - Google Patents

2-carboxamide-benzimidazoles useful in the treatment and prevention of isochemic reperfusion injury

Info

Publication number
IL150525A0
IL150525A0 IL15052501A IL15052501A IL150525A0 IL 150525 A0 IL150525 A0 IL 150525A0 IL 15052501 A IL15052501 A IL 15052501A IL 15052501 A IL15052501 A IL 15052501A IL 150525 A0 IL150525 A0 IL 150525A0
Authority
IL
Israel
Prior art keywords
isochemic
carboxamide
prevention
treatment
reperfusion injury
Prior art date
Application number
IL15052501A
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL150525A0 publication Critical patent/IL150525A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15052501A 2000-02-09 2001-02-08 2-carboxamide-benzimidazoles useful in the treatment and prevention of isochemic reperfusion injury IL150525A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18123400P 2000-02-09 2000-02-09
PCT/US2001/004211 WO2001058878A1 (en) 2000-02-09 2001-02-08 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury

Publications (1)

Publication Number Publication Date
IL150525A0 true IL150525A0 (en) 2003-02-12

Family

ID=22663432

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15052501A IL150525A0 (en) 2000-02-09 2001-02-08 2-carboxamide-benzimidazoles useful in the treatment and prevention of isochemic reperfusion injury

Country Status (7)

Country Link
EP (1) EP1263736A1 (en)
JP (1) JP2003522759A (en)
AU (1) AU2001236821A1 (en)
CA (1) CA2399795A1 (en)
IL (1) IL150525A0 (en)
NO (1) NO20023752L (en)
WO (1) WO2001058878A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872827B2 (en) 2002-04-26 2005-03-29 Chembridge Research Laboratories, Inc. Somatostatin analogue compounds
CN108456171B (en) * 2018-03-16 2021-07-27 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） FLT3/ITD mutant inhibitor and application thereof in tumor prevention and treatment medicines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL345906A1 (en) * 1998-06-04 2002-01-14 Abbott Lab Cell adhesion-inhibiting antinflammatory compounds

Also Published As

Publication number Publication date
WO2001058878A1 (en) 2001-08-16
AU2001236821A1 (en) 2001-08-20
NO20023752D0 (en) 2002-08-08
NO20023752L (en) 2002-10-09
CA2399795A1 (en) 2001-08-16
JP2003522759A (en) 2003-07-29
EP1263736A1 (en) 2002-12-11

Similar Documents

Publication Publication Date Title
AU8870701A (en) Materials and methods for the treatment or prevention of obesity
HK1054225A1 (en) Mch antagonists and their use in the treatment of obesity
HK1061669A1 (en) Processes and compositions for water treatment
ZA200300788B (en) Improvements in and relating to the use of honey in dressings.
IL156340A0 (en) 3-indoline derivatives useful in the treatment of psychiatric and neurologic disorders
HUP0400069A3 (en) Pharmaceutical combinations and their use in preventing and treating the thrombosis
AU7790401A (en) Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
GB2314273B (en) The use of TCET in the prophylaxis and treatment of allergies
GB9912159D0 (en) Improvements in and relating to the treatment of water
PL352333A1 (en) Dihydrobenzodiazepines and use of same in treatment of dislipidemia
AU2002243363A8 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
AU6814601A (en) Use of mutant herpes viruses and anticancer agents in the treatment of cancer
HUP0302738A3 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
IL150525A0 (en) 2-carboxamide-benzimidazoles useful in the treatment and prevention of isochemic reperfusion injury
AU7570201A (en) Phenylethylamine derivatives and their use in the treatment of melanoma
GB0004534D0 (en) Hair treatment compositions and their use
GB0007217D0 (en) Materials and methods relating to the treatment of leukaemias
GB0004535D0 (en) Hair treatment compositions and their use
ZA200103250B (en) The treatment of immunomodulatory related and other diseases or conditions.
GB0013115D0 (en) Biological materials and methods for use in the prevention or treatment of infections
GB0004648D0 (en) Compositions and mixtures for the treatment of skin
GB0020170D0 (en) Sedative materials and treatment
GB0027574D0 (en) Phenylethylamine derivatives and their use in the treatment of melanoma
GB0018376D0 (en) Phenylethylamine derivatives and their use in the treatment of melanoma
AU2291102A (en) Compositions and methods for the treatment of skin damage